mustangbio.com (MBIO) - Company Revenue

Symbol and logo of brand Mustang Bio (MBIO)

Mustang Bio, Inc. (MBIO) focuses on developing CAR-T and gene therapies to combat cancer and rare pathologies while minimizing capital risks. The company's commercial revenue confirms this strategy, with the indicator amounting to 0.00. Simultaneously, the business adheres to ESG standards for bio-waste disposal and is implementing eco-friendly packaging. The stability of research is ensured through redundant supply chains for biomaterials.

Mustang Bio Inc (MBIO) Company Revenue: for the period 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for Mustang Bio (MBIO)

- market capitalization indicators:
Comprehensive company analysis:Mustang Bio MBIO
Flagship merchandise of mustangbio.com

This metric aggregates all cash inflows from product sales, serving as a primary indicator of the business's commercial viability. The metric captures the actual volume of closed deals, allowing investors to filter out market noise and assess real cash flow. For Mustang Bio, Inc. (MBIO), this calculation reflects the monetization of developments in the field of CAR-T gene therapy. By analyzing the revenue chart for Mustang Bio, Inc. on GURU.Markets, one can determine the pace of commercialization for innovative cancer treatment methods.

Key competitors

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume MGX|DTIL (precisionbiosciences.com) - Revenue and Sales Volume|Company Sales Volume GBIO (Generation Bio Co.)|Company Revenue Boundless Bio (BOLD)|Exicure - Company Sales Volume|Revenue and Sales Volume IMNN (imunon.com)|Company Gross Revenue Phio Pharmaceuticals (PHIO)|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales